Avaliação de marcadores neuroquímicos e neuroinflamatórios periféricos em pacientes com acidente vascular cerebral isquêmico (AVCi) leve a moderado
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Introduction: Acute ischemic stroke (AIS) leads to a sudden reduction in cerebral
blood flow, starts an acute neuroinflammation process due to tissue hypoxia, which
leads the perpetuation of a chronic process and consequent neuronal damage and
death. Cognitive impairment and post-stroke dementia are known sources of morbidity
and mortality for affected patients. Therefore, early screening of potential inflammatory
biomarkers may contribute to severity stratification and prediction of cognitive
outcomes. Methodology: Individuals with minor to moderate AIS (n=21) were
recruited and compared with controls (n=21) matched for age, sex and education. Data
were collected using the following instruments: National Institutes of Health Stroke
Scale (NIHSS), Mini-Mental State Examination (MMSE), Frontal Assessment Battery
(FAB), and Visual Memory Test of the Brief Cognitive Battery (VMT) up to seven days
after the stroke ictus. Peripheral blood plasma samples were collected to measure
calcium-binding protein B S100 (S100B), fractalkine (CX3CL1), brain-derived
neurotrophic factor (BDNF), neuron-specific enolase (NSE), amyloid precursor protein
(APP), neurofilament light chain (NFL), and ubiquitin carboxy-terminal hydrolase L1
(UCHL-1). For group comparisons, the Mann–Whitney test and Fisher’s exact test or
chi-square test were used. Correlation between biomarkers and clinical parameters
was assessed through simple linear regression. Results: The groups were similar with
MMSE scores. The stroke group showed lower FAB scores (p = 0.002). On the VMT,
AIS patients demonstrated decrease in immediate memory (p = 0.001), learning (p =
0.045), recall (p = 0.030), and recognition (p = 0.037). Individuals with AIS had
increased UCHL-1 (p = 0.048) and NSE (p = 0.005) levels, and reduced S100B (p =
0.047). CX3CL1, BDNF, APP, and NFL concentrations were similar between groups.
CX3CL1 and NSE concentrations were associated with worse FAB performance; NSE
and APP concentrations correlated with impairments in recall, recognition, and learning
on the VMT. S100B and NSE levels were associated with NIHSS scores. Conclusion:
The results suggest NSE, and S100B has potential as plasma biomarkers of cognitive
decline and AIS severity.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

